Oligomerix Announces Series B Extension Raise of $2.7 Million to Support Phase 1 Clinical Development

Oligomerix > News > Oligomerix Announces Series B Extension Raise of $2.7 Million to Support Phase 1 Clinical Development

June 3, 2022 By vera

This article is sourced from an external publication. Read the original →

https://oligomerix.com/wp-content/uploads/2022/06/Oligomerix-Series-B-Extension-Raise-June-1^J-2022-V2-CLEAN-.pdf